NCT07731737

Brief Summary

The current study will be a single-blinded, two-arm parallel group randomized clinical trial involving 48 participants. The trial will compare Pressure Biofeedback training with Bolster Foam Roll training. Interventions will be delivered three times per week for eight weeks. The primary outcomes will include pain intensity, functional status, and muscle activation. Assessments will be conducted at baseline (week 0), mid-intervention (week 4), post-intervention (week 8), and follow-up (week 12). The study will be conducted at the outpatient departments of Sir Ganga Ram Hospital (SGRH) and Mayo Hospital Lahore. The hypothesis is that there is a difference between Pressure Biofeedback Training and Bolster Foam Feedback Training regarding pain reduction, muscle activation, and patient-reported quality of life compared to Bolster Foam rolling training among knee osteoarthritis patients.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
3mo left

Started May 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress55%
May 2026Oct 2026

Study Start

First participant enrolled

May 1, 2026

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 23, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 28, 2026

Completed
18 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2026

Last Updated

July 28, 2026

Status Verified

July 1, 2026

Enrollment Period

4 months

First QC Date

July 23, 2026

Last Update Submit

July 23, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Pain Intensity assessed via Numeric Pain Rating Scale (NPRS)

    Knee pain intensity will be assessed using the Numeric Pain Rating Scale (NPRS). Participants will rate their current knee pain, as well as their worst and best pain over the last 24 hours, on an 11-point integers scale. On this scale, 0 indicates "No pain" and 10 indicates "worst pain imaginable

    Baseline (week 0), Mid-Intervention (week 4), Post-Intervention (Week 8), and Follow-up (Week 12)

  • Functional Status and Quality of Life assessed via WOMAC Index

    The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) will be utilized as the primary outcome measure for functional status and disease-specific quality of life. The index comprises 24 items covering three dimensions: Pain (Score range: 0-20), Stiffness (Score range: 0-8), and Physical Function (Score range: 0-68). Items are scored on a 5-point Likert scale (0=none to 4=Extreme), where higher aggregate scores indicate greater disability

    Baseline (week 0), Mid-Intervention (week 4), Post-Intervention (Week 8), and Follow-up (Week 12)

  • Quadriceps Muscle Activation assessed via Modified Sphygmomanometer Test (MST)

    Quadriceps muscle activation will be assessed using the Modified Sphygmomanometer Test. A cuff is placed under the popliteal fossa and inflated to a baseline of 40 mmHg. The patient performs a Maximum Voluntary Isometric Contraction (MVIC), and the peak pressure sustained for 3 seconds is recorded. The final outcome is the change in pressure (Peak - Baseline) calculated from the average of 3 trials

    Baseline (week 0), Mid-Intervention (week 4), Post-Intervention (Week 8), and Follow-up (Week 12)

Study Arms (2)

Pressure Biofeedback Training

EXPERIMENTAL

Participants will receive 45-minute sessions including warm-up and conventional physiotherapy. For targeted isometric training, participants lie supine with a Pressure Biofeedback Unit airbag under the popliteal fossa inflated to 60 mmHg. They press the knee downward to move the dial up 20-40 mmHg, holding for 10 seconds across 3 sets of 10 repetitions

Other: pressure Biofeedback Training

Bolster Foam Feedback Training

ACTIVE COMPARATOR

Participants will receive the same 45-minute sessions with warm-up and conventional physiotherapy. For targeted isometric training, participants lie supine with a firm high-density foam bolster under the knee. They are instructed to "crush the foam" into the table to feel the resistance, holding for 10 seconds across 3 sets of 10 repetitions

Other: Bolster Foam Roll Training

Interventions

This intervention combines a standard land-based therapeutic exercise protocol with visual feedback for targeted isometric quadriceps activation. During a 45-minute session, participants first complete warm-up and conventional strengthening exercises (e.g., straight leg raises, hip abduction, step-ups). For the specific isometric component, participants lie supine with a Pressure Biofeedback Unit (PBU) airbag placed under the popliteal fossa, inflated to a baseline of 60 mmHg. They are instructed to press the knee downward to increase the dial reading by 20-40 mmHg and hold it steady for 10 seconds. This is performed for 3 sets of 10 repetitions to counteract Arthrogenic Muscle Inhibition (AMI).

Pressure Biofeedback Training

Participants will complete a 45-minute exercise session consisting of a warm-up and conventional physiotherapy exercises (straight leg raises, side-lying hip abduction, step-ups, mini-squats, and stretches). For the targeted isometric component, participants are positioned supine with a firm high-density foam bolster placed under the knee. They are instructed to "crush the foam" into the table to feel the physical resistance, holding the contraction for 10 seconds. They will complete 10 repetitions across 3 sets.

Bolster Foam Feedback Training

Eligibility Criteria

Age45 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient diagnosis with Grade II knee Osteoarthritis.
  • Age between 45 and 65 years, encompassing the typical onset of symptomatic OA.
  • Both genders Male and Female are included.
  • Symptomatic patients meeting the following American College of Rheumatology criteria: average pain score ≥ 3 in the last week on the numerical rating scale, morning stiffness \< 30 min, and joint crepitus

You may not qualify if:

  • History of knee surgery (TKA, HTO, ACLR) or arthroscopy in the affected knee within the last 6 months.
  • Intra-articular corticosteroid or hyaluronic acid injections within the last 3 months.
  • Neurological conditions affecting lower limb motor control (e.g., Stroke, Parkinson's, Radiculopathy).
  • Acute infection, tumor, or fracture around the knee joint.
  • Severe cognitive impairment or inability to follow visual/tactile cues.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lahore University of Biological and Applied Sciences

Lahore, 54000, Pakistan

RECRUITING

MeSH Terms

Conditions

Osteoarthritis, KneeOsteoarthritis

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • WHO

    Lahore University of Biological and Applied Sciences

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sahar Fatima, Sidra Principal Investigator

CONTACT

Dr. Shoaib Waqas Waqas

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
This will be a single-blinded study where the outcome assessor will be kept completely blinded to the participants' group allocation. Due to the visible nature of the feedback tools (gauge versus foam), the intervention administrators and the patients cannot be blinded
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a randomized clinical trial utilizing a two-arm parallel group design. Participants will be randomly assigned in a 1:1 ratio to receive either Pressure Biofeedback training or Bolster Foam Roll training
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 23, 2026

First Posted

July 28, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

August 15, 2026

Study Completion (Estimated)

October 15, 2026

Last Updated

July 28, 2026

Record last verified: 2026-07

Locations